Oncolytic Viruses as a Novel Therapeutic Approach for Colorectal Cancer: Mechanisms, Current Advances, and Future Directions. [PDF]
Pérez-Domínguez F +4 more
europepmc +1 more source
The 16th International Oncolytic Virus Conference: Advancing oncolytic virotherapy by balancing anti-tumor and anti-viral immunity. [PDF]
Stavrakaki E +3 more
europepmc +1 more source
Efficacy, Safety and Predictive Biomarkers of Oncolytic Virus Therapy in Solid Tumors: A Systematic Review and Meta-Analysis. [PDF]
El-Tanani M +8 more
europepmc +1 more source
Constitutive NF-kB Activation Is Amplified by VSV in Aggressive PC3 Prostate Cancer Cells That Resist Viral Oncolysis. [PDF]
Abdelmageed AA +7 more
europepmc +1 more source
Experimental models for developing oncolytic virotherapy for metastatic prostate cancer. [PDF]
Chen YC, Figueiredo ML.
europepmc +1 more source
Author Correction: An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy. [PDF]
Naveed M +8 more
europepmc +1 more source
Editorial for the Special Issue "Glioblastoma: What Do We Know?" [PDF]
Yu SP.
europepmc +1 more source
Reply to "Letter to the Editor: Targeted Inhibition of p21 Promotes the Growth of Breast Cancer Cells and Impairs the Tumor-Killing Effect of the Vaccinia Virus". [PDF]
Sultan MH, Jia X, Wang Y.
europepmc +1 more source
Oncolytic virus-induced IL-1β<sup>+</sup> monocyte-IL-6<sup>+</sup> CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer. [PDF]
Li F +21 more
europepmc +1 more source
Serum extracellular vesicles containing adenoviral E1A-DNA as a predictive biomarker for liquid biopsy in oncolytic adenovirus therapy. [PDF]
Yagi C +17 more
europepmc +1 more source

